Educational Intervention to Reduce Drug-related Hospitalizations in Elderly Primary Health Care Patients

Sponsor
Karolinska Institutet (Other)
Overall Status
Completed
CT.gov ID
NCT01732302
Collaborator
Region Stockholm (Other)
69
1
2
10
6.9

Study Details

Study Description

Brief Summary

The purpose of this study is to determine whether an educational intervention given towards health care providers working in primary health care centers can reduce inappropriate prescribing in the elderly patient and thus reduce number and length of drug-related hospitalizations as well as number of emergency department visits in this patient group.

Condition or Disease Intervention/Treatment Phase
  • Other: Educational intervention
N/A

Detailed Description

Inappropriate medication in the elderly patient leads to substantial morbidity, possibly causing up to 20% of hospitalizations in this patient group (1). To improve prescribing and thus reduce undesired drug effects is a great challenge for doctors and nurses in primary health care.

Performance of drug utilization reviews is recommended in order to reduce the negative impact of inappropriate prescribing in the elderly. However, scientific evidence on their efficacy is lacking, especially regarding patient-related health outcomes (2,3). Most studies are carried out in inpatient care, making it difficult to draw conclusions regarding primary health care (2). Moreover, studies in this scientific field diverge regarding the content and structure of drug utilization reviews, which implies that comparison between studies becomes challenging, if not impossible.

This trial aims at educating health care providers in how to perform drug utilization reviews, and to help them implement theory into practice.

Study Design

Study Type:
Interventional
Actual Enrollment :
69 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Prevention
Official Title:
Educational Intervention to Reduce Drug-related Hospitalizations and Visits in Emergency Departments in Elderly Primary Health Care Patients - a Cluster-randomized Controlled Trial
Study Start Date :
Nov 1, 2012
Actual Primary Completion Date :
Sep 1, 2013
Actual Study Completion Date :
Sep 1, 2013

Arms and Interventions

Arm Intervention/Treatment
Experimental: Educational intervention

Primary health care centers (PHCC) in the intervention group will be visited twice by a pharmacist within a period of three months. At the first visit, an educational intervention will focus on two properties: on the one hand, feed-back of actual patient data of the PHCC illustrating the primary-health-care-specific characteristics of inappropriate prescribing in the elderly patient will be given. Education of relevant subjects will be given in relation to detected problems. On the other hand, a clinical routine regarding the performance of drug utilization reviews will be developed in cooperation with the health care providers. At the second visit 3 months later, the developed concept will be critically reviewed and eventually developed further.

Other: Educational intervention
Primary health care centers (PHCC) in the intervention group will be visited twice by a pharmacist within a period of three months. At the first visit, an educational intervention will focus on two properties: on the one hand, feed-back of actual patient data of the PHCC illustrating the primary-health-care-specific characteristics of inappropriate prescribing in the elderly patient will be given. Education of relevant subjects will be given in relation to detected problems. On the other hand, a clinical routine regarding the performance of drug utilization reviews will be developed in cooperation with the health care providers. At the second visit 3 months later, the developed concept will be critically reviewed and eventually developed further.

No Intervention: Delayed educational intervention

Primary health care centers in the delayed intervention group will receive the same intervention as described above with 9 months delay.

Outcome Measures

Primary Outcome Measures

  1. Composite outcome: Unplanned hospitalisation or emergency department visit [9 months]

Secondary Outcome Measures

  1. Unplanned hospitalisation [9 months]

  2. Emergency department visit [9 months]

  3. Length of hospital stay [9 months]

  4. All cause mortality [9 months]

  5. Number of drug utilization reviews [9 months]

  6. Number of patients with polypharmacy [9 months]

    polypharmacy: 5-9 drugs/patient excessive polypharmacy: 10 and more drugs/patient

  7. Inappropriate drug use according to national guidelines [9 months]

    see link

  8. Number of patients with contraindicated drugs regarding renal function [9 months]

  9. Number of drugs with inappropriate drug dose regarding renal function [9 months]

  10. Number of drug interactions [9 months]

Eligibility Criteria

Criteria

Ages Eligible for Study:
65 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • primary health care center in Stockholm County

  • authorized by Stockholm County Council since at least 3 years

  • at least 5% of patients attributed to primary health care center are 65 years and older

  • primary health care center takes care of at least 10 home care patients

Exclusion Criteria:
  • less than 3000 patients listed in primary health care center

  • primary health care centers where researchers carrying out the present study work

Contacts and Locations

Locations

Site City State Country Postal Code
1 Centre for Family Medicine, Dept of Neurobiology, Care sciences and Society, Karolinska Institutet Huddinge Sweden 14183

Sponsors and Collaborators

  • Karolinska Institutet
  • Region Stockholm

Investigators

  • Principal Investigator: Jan Hasselström, MD, PhD, Centre for Family Medicine, Dept of Neurobiology, Care sciences and Society, Karolinska Institutet

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Lars Agreus, Professor, Karolinska Institutet
ClinicalTrials.gov Identifier:
NCT01732302
Other Study ID Numbers:
  • 2012 1266-31
First Posted:
Nov 22, 2012
Last Update Posted:
Oct 21, 2013
Last Verified:
Oct 1, 2013
Keywords provided by Lars Agreus, Professor, Karolinska Institutet
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 21, 2013